US Stock MarketDetailed Quotes

Acumen Pharmaceuticals (ABOS)

Watchlist
  • 2.820
  • +0.130+4.83%
Close Apr 17 16:00 ET
  • 2.830
  • +0.010+0.35%
Post 20:01 ET
203.64MMarket Cap-1.41P/E (TTM)

Acumen Pharmaceuticals (ABOS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
8.61%123.83M
-36.36%25.2M
-17.83%26.51M
71.24%41.75M
70.87%30.37M
86.49%114.02M
114.20%39.6M
101.17%32.27M
80.89%24.38M
35.32%17.77M
Selling and administrative expenses
-6.29%18.95M
-7.06%4.67M
-9.43%4.55M
-4.60%4.63M
-4.15%5.1M
7.43%20.22M
-3.18%5.03M
3.25%5.02M
11.58%4.85M
20.42%5.33M
-General and administrative expense
-6.29%18.95M
-7.06%4.67M
-9.43%4.55M
-4.60%4.63M
-4.15%5.1M
7.43%20.22M
-3.18%5.03M
3.25%5.02M
11.58%4.85M
20.42%5.33M
Research and development costs
11.82%104.89M
-40.62%20.53M
-19.37%21.97M
90.06%37.13M
102.96%25.27M
121.65%93.8M
160.05%34.57M
143.73%27.25M
113.87%19.53M
42.88%12.45M
Operating profit
-8.61%-123.83M
36.36%-25.2M
17.83%-26.51M
-71.24%-41.75M
-70.87%-30.37M
-86.49%-114.02M
-114.20%-39.6M
-101.17%-32.27M
-80.89%-24.38M
-35.32%-17.77M
Net non-operating interest income expense
-68.55%3.22M
-87.98%235K
-76.95%571K
-65.54%969K
-51.81%1.45M
0.38%10.25M
-41.99%1.96M
-20.71%2.48M
49.26%2.81M
64.03%3.01M
Non-operating interest income
-47.98%7.45M
-55.82%1.32M
-53.22%1.64M
-47.20%2.02M
-38.30%2.47M
32.68%14.32M
-24.27%2.99M
12.16%3.5M
102.55%3.82M
118.61%4.01M
Non-operating interest expense
3.83%4.22M
4.82%1.09M
3.99%1.07M
4.18%1.05M
2.30%1.02M
600.17%4.07M
78.49%1.04M
--1.03M
--1M
--1M
Other net income (expense)
-150.45%-726K
-135.66%-174K
-2,313.04%-509K
-116.38%-169K
221.15%126K
199.72%1.44M
135.34%488K
154.76%23K
6,550.00%1.03M
-2,500.00%-104K
Gain on sale of security
-128.93%-460K
-130.91%-170K
-4,300.00%-440K
-103.64%-40K
480.00%190K
216.91%1.59M
--550K
---10K
--1.1M
---50K
Other non- operating income (expenses)
-76.16%-266K
93.55%-4K
-309.09%-69K
-89.71%-129K
-18.52%-64K
-81.93%-151K
-195.24%-62K
178.57%33K
-325.00%-68K
-1,250.00%-54K
Income before tax
-18.57%-121.34M
32.34%-25.14M
11.13%-26.45M
-99.40%-40.95M
-93.61%-28.8M
-95.39%-102.33M
-125.22%-37.15M
-129.72%-29.77M
-76.89%-20.54M
-31.54%-14.87M
Income tax
Net income
-18.57%-121.34M
32.34%-25.14M
11.13%-26.45M
-99.40%-40.95M
-93.61%-28.8M
-95.39%-102.33M
-125.22%-37.15M
-129.72%-29.77M
-76.89%-20.54M
-31.54%-14.87M
Net income continuous Operations
-18.57%-121.34M
32.34%-25.14M
11.13%-26.45M
-99.40%-40.95M
-93.61%-28.8M
-95.39%-102.33M
-125.22%-37.15M
-129.72%-29.77M
-76.89%-20.54M
-31.54%-14.87M
Minority interest income
Net income attributable to the parent company
-18.57%-121.34M
32.34%-25.14M
11.13%-26.45M
-99.40%-40.95M
-93.61%-28.8M
-95.39%-102.33M
-125.22%-37.15M
-129.72%-29.77M
-76.89%-20.54M
-31.54%-14.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.57%-121.34M
32.34%-25.14M
11.13%-26.45M
-99.40%-40.95M
-93.61%-28.8M
-95.39%-102.33M
-125.22%-37.15M
-129.72%-29.77M
-76.89%-20.54M
-31.54%-14.87M
Basic earnings per share
-16.96%-2
33.87%-0.41
12.00%-0.44
-100.00%-0.68
-92.00%-0.48
-58.33%-1.71
-113.79%-0.62
-108.33%-0.5
-21.43%-0.34
10.71%-0.25
Diluted earnings per share
-16.96%-2
33.87%-0.41
12.00%-0.44
-100.00%-0.68
-92.00%-0.48
-58.33%-1.71
-113.79%-0.62
-108.33%-0.5
-21.43%-0.34
10.71%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 8.61%123.83M-36.36%25.2M-17.83%26.51M71.24%41.75M70.87%30.37M86.49%114.02M114.20%39.6M101.17%32.27M80.89%24.38M35.32%17.77M
Selling and administrative expenses -6.29%18.95M-7.06%4.67M-9.43%4.55M-4.60%4.63M-4.15%5.1M7.43%20.22M-3.18%5.03M3.25%5.02M11.58%4.85M20.42%5.33M
-General and administrative expense -6.29%18.95M-7.06%4.67M-9.43%4.55M-4.60%4.63M-4.15%5.1M7.43%20.22M-3.18%5.03M3.25%5.02M11.58%4.85M20.42%5.33M
Research and development costs 11.82%104.89M-40.62%20.53M-19.37%21.97M90.06%37.13M102.96%25.27M121.65%93.8M160.05%34.57M143.73%27.25M113.87%19.53M42.88%12.45M
Operating profit -8.61%-123.83M36.36%-25.2M17.83%-26.51M-71.24%-41.75M-70.87%-30.37M-86.49%-114.02M-114.20%-39.6M-101.17%-32.27M-80.89%-24.38M-35.32%-17.77M
Net non-operating interest income expense -68.55%3.22M-87.98%235K-76.95%571K-65.54%969K-51.81%1.45M0.38%10.25M-41.99%1.96M-20.71%2.48M49.26%2.81M64.03%3.01M
Non-operating interest income -47.98%7.45M-55.82%1.32M-53.22%1.64M-47.20%2.02M-38.30%2.47M32.68%14.32M-24.27%2.99M12.16%3.5M102.55%3.82M118.61%4.01M
Non-operating interest expense 3.83%4.22M4.82%1.09M3.99%1.07M4.18%1.05M2.30%1.02M600.17%4.07M78.49%1.04M--1.03M--1M--1M
Other net income (expense) -150.45%-726K-135.66%-174K-2,313.04%-509K-116.38%-169K221.15%126K199.72%1.44M135.34%488K154.76%23K6,550.00%1.03M-2,500.00%-104K
Gain on sale of security -128.93%-460K-130.91%-170K-4,300.00%-440K-103.64%-40K480.00%190K216.91%1.59M--550K---10K--1.1M---50K
Other non- operating income (expenses) -76.16%-266K93.55%-4K-309.09%-69K-89.71%-129K-18.52%-64K-81.93%-151K-195.24%-62K178.57%33K-325.00%-68K-1,250.00%-54K
Income before tax -18.57%-121.34M32.34%-25.14M11.13%-26.45M-99.40%-40.95M-93.61%-28.8M-95.39%-102.33M-125.22%-37.15M-129.72%-29.77M-76.89%-20.54M-31.54%-14.87M
Income tax
Net income -18.57%-121.34M32.34%-25.14M11.13%-26.45M-99.40%-40.95M-93.61%-28.8M-95.39%-102.33M-125.22%-37.15M-129.72%-29.77M-76.89%-20.54M-31.54%-14.87M
Net income continuous Operations -18.57%-121.34M32.34%-25.14M11.13%-26.45M-99.40%-40.95M-93.61%-28.8M-95.39%-102.33M-125.22%-37.15M-129.72%-29.77M-76.89%-20.54M-31.54%-14.87M
Minority interest income
Net income attributable to the parent company -18.57%-121.34M32.34%-25.14M11.13%-26.45M-99.40%-40.95M-93.61%-28.8M-95.39%-102.33M-125.22%-37.15M-129.72%-29.77M-76.89%-20.54M-31.54%-14.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.57%-121.34M32.34%-25.14M11.13%-26.45M-99.40%-40.95M-93.61%-28.8M-95.39%-102.33M-125.22%-37.15M-129.72%-29.77M-76.89%-20.54M-31.54%-14.87M
Basic earnings per share -16.96%-233.87%-0.4112.00%-0.44-100.00%-0.68-92.00%-0.48-58.33%-1.71-113.79%-0.62-108.33%-0.5-21.43%-0.3410.71%-0.25
Diluted earnings per share -16.96%-233.87%-0.4112.00%-0.44-100.00%-0.68-92.00%-0.48-58.33%-1.71-113.79%-0.62-108.33%-0.5-21.43%-0.3410.71%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More